ENTR-601-45
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ENTR-601-45, covering 2026-03-09 to 2026-03-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45 [Phase 1, Phase 2]